SpaceX Goes Public at $135 a Share. Is It a Buy at That Price?

SpaceX is preparing a $135 IPO with a roughly $2 trillion valuation, but only about 5% of total equity will be offered to the public. The stock would debut at 92 times trailing 12-month sales, well above the S&P 500's 3.7x and Nasdaq-100's 6.7x averages, making the article broadly cautious on retail participation despite more than 20% of shares being reserved for retail investors. The piece argues the pricing leaves limited upside unless growth and profitability improve materially.

Analysis

This is less an IPO and more a scarcity-driven liquidity event: only a sliver of value is being monetized into a market that has been trained to pay for optionality on frontier tech. The immediate winner is the underwriting and secondary ecosystem, not the issuer’s fundamentals; the first-order price discovery will likely be dominated by flow, index-chasing, and retail FOMO rather than discounted cash flow. That creates a classic post-deal setup where implied growth expectations start from a nearly impossible base, leaving very little room for execution misses.

The key second-order effect is competitive signaling across late-stage private markets. A near-$2T headline valuation raises the bar for every capital-intensive private AI/space/defense platform, but it also makes them more reluctant to come public unless they can command similar scarcity premiums. That can keep venture liquidity frozen for longer, while pushing public-market investors toward adjacent beneficiaries with cleaner financial profiles, where the same “frontier growth” narrative can be bought at a fraction of the multiple.

The risk is that the stock becomes a volatility product after the first lockup windows. When supply expands, the marginal buyer has to absorb insider monetization plus disappointed momentum holders, and that often matters more than operating results over the first 3-6 months. If sentiment cools even modestly, the multiple can compress far faster than the business can compound, making the setup asymmetric for post-IPO longs but attractive for hedged shorts or relative-value expressions.

Contrarianly, the consensus may be underestimating how much this can help legacy public beneficiaries of the “space + AI infrastructure” spend cycle. The real trade may not be the issuer itself, but the picks-and-shovels layer that gets incremental capex without the same valuation burden—especially names with existing public liquidity, recurring revenue, and lower execution risk.

Key Decisions for Investors

• Avoid chasing the IPO on day 1; wait 4-8 weeks for post-listing supply discovery and early lockup-related weakness before considering any long exposure.
• Short the hype premium via call spreads or outright short against a borrowable proxy if available; target a 3-6 month horizon where multiple compression can outpace revenue growth.
• Long NDAQ on any broad IPO frenzy pullback: elevated issuance and retail participation should support trading volumes and listing fees over the next 1-2 quarters, with lower fundamental risk than the headline deal.
• Maintain a relative-value long NVDA / short speculative late-stage IPO basket: if the market rewards frontier narratives indiscriminately, established AI capex beneficiaries should re-rate more cheaply on superior visibility.
• Watch INTC as an indirect beneficiary of “national strategic tech” flows; if the market starts underwriting industrial-policy winners, it can catch a sympathy bid over 1-3 months despite weaker standalone fundamentals.